New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA
VYKOURA is a newly approved medication (marketing start date: 02/03/2026) containing leucovorin calcium, a prescription injectable drug used in hospital
Tag: betadex sulfobutylether sodium
FDA grants approval to Axsome Therapeutics’ migraine medication containing Betadex Sulfobutylether Sodium
The U.S. Food and Drug Administration has approved Axsome Therapeutics’ new migraine treatment tablet on 30 January 2025 [1]. Marketed